JNJ:Johnson & Johnson Snapshot | Charting | News | Options
$148.53 NYSE 6:06p ET
April 8 '24 		Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference BusinessWire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
     BusinessWire

    Johnson & Johnson (NYSE: JNJ) will participate in the 2024 RBC Capital Markets Global Healthcare Conference on Wednesday, May 15th, at the InterContinental Barclay Hotel, New York. Tim Schmid, Executive Vice President, Worldwide Chairman, MedTech, will represent the Company in a session scheduled at 11:00 am (Eastern Time).

    Full Story →

    Headline News
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq - SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE - MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
    12:48p ET April 8 '24 GlobeNewswire
    CARVYKTI(R) is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy
    11:22p ET April 5 '24 PR Newswire
    SHAREHOLDER ALERT: Weiss Law Investigates Shockwave Medical, Inc.
    3:46p ET April 5 '24 ACCESSWIRE
    More News →
    Day  0.69%Week  2.60%Month  4.31%More Charting →
    April 24 '24. Markets Closed.
    Last $148.53
    Day change   0.69%$1.03
    Open $148.14
    Gap at open $1.42
    Previous close $149.56
    Trading volume 9,756,246
    10 Day avg vol. 9,555,265
    Shares out. 2.4Bil
    Market cap. $357.9Bil
    Trading activity Above Avg.
    Previous data from yesterday, April 23 '24.

    Historical Price Performance
    3 month   6.91% 
    6 month   2.01% 
    1 year   10.08% 
    2 year   20.15% 

    Earnings
    Previous 12m $7.51
    Next 12m Estimate $10.66
    P/E ratio 19.8x
    Revenue 81,796Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.